Join
Live feed
·
PRReleasevia Quantisnow
Veracyte Inc. logo

Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte's Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy

ByQuantisnow·Wall Street's wire, on your screen.
VCYT· Veracyte Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCYT (Veracyte Inc.) and more on Quantisnow.